4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §102 only | 1 (25%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMATO JR, DENNIS IGNATIUS | 1 | 56.3% | +70.0% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.3% | +42.1% |
| HOLLAND, PAUL J | 1 | 57.5% | +64.7% |
| DABKOWSKI, ERINNE R | 1 | 55.8% | +69.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18549804 | COMPOSITION AND AMELIORATING AGENT HAVING INFLAMMATION REDUCING EFFECT | OGUNBIYI, OLUWATOSIN A | 120d overdue |
| 16617497 | USE OF CITRULLINE AND GLUTATHIONE TO INCREASE MUSCLE MASS | DABKOWSKI, ERINNE R | 78d overdue |
| 18002349 | METHOD FOR PRODUCING DIPEPTIDE | HOLLAND, PAUL J | 60d overdue |
| 18699491 | MICROORGANISM HAVING ABILITY TO PRODUCE N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE AND METHOD FOR PRODUCING N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE USING SAID MICROORGANISM | ARMATO JR, DENNIS IGNATIUS | 41d |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 1645 | 1 |
| 1656 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18699491 | MICROORGANISM HAVING ABILITY TO PRODUCE N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE AND METHOD FOR PRODUCING N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE USING SAID MICROORGANISM | ARMATO JR, DENNIS IGNATIUS | 1651 | §102 | Non-Final OA | 41d | Pending | Apr 08, 2024 |
| 18549804 | COMPOSITION AND AMELIORATING AGENT HAVING INFLAMMATION REDUCING EFFECT | OGUNBIYI, OLUWATOSIN A | 1645 | Other | Non-Final OA | 120d overdue | Pending | Sep 08, 2023 |
| 18002349 | METHOD FOR PRODUCING DIPEPTIDE | HOLLAND, PAUL J | 1656 | §103 | Final Rejection | 60d overdue | Pending | Dec 19, 2022 |
| 16617497 | USE OF CITRULLINE AND GLUTATHIONE TO INCREASE MUSCLE MASS | DABKOWSKI, ERINNE R | 1654 | §103 | Non-Final OA | 78d overdue | Pending | Nov 26, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial